From the Journals
From the Journals
Hypertension heightens risk for severe COVID-19, even in the fully vaxxed
Vaccinated and boosted adults with high blood pressure were more than twice likely to be hospitalized for COVID-19 than were those without...
From the Journals
Immune response may explain brain damage after COVID-19
Antibodies appear involved in an attack on the cells lining the brain’s blood vessels.
From the Journals
Lung cancer treatment combo may be effective after ICI failure
Phase 2 trial offers hope of a chemotherapy-free option for patients with advanced NSCLC.
From the Journals
Race-specific spirometry may miss emphysema diagnoses
Spirometry might be insufficient to identify respiratory problems across all populations.
From the Journals
Steroids no cure for obstructive sleep apnea in children
There was a statistically significant but not clinically relevant reduction in the obstructive apnea hypopnea index.
From the Journals
RV dysfunction slams survival in acute COVID, flu, pneumonia
The findings suggest that abnormal RV findings should be considered a mortality risk marker in patients with acute respiratory illness.
From the Journals
Best meds for insomnia identified?
For many insomnia medications, there is a “striking” and “appalling” lack of long-term data.
From the Journals
Cancer drug significantly cuts risk for COVID-19 death
The data are “pretty impressive and in a group of patients that we really have limited things to offer.”
From the Journals
Minimal differences between biologics approved for severe asthma
“We know relatively little of the comparative effectiveness or safety of biologics approved for the treatment of asthma.”
From the Journals
Pulse oximeters lead to less oxygen supplementation for people of color
Readings are affected by various surface pigmentations, upping risk of hidden hypoxemia in those with darker skin.